Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL673P refers to a pseudogene derived from the 7SL RNA, an essential component of the signal recognition particle (SRP) involved in the targeting and translocation of secretory and membrane proteins in eukaryotic cells[3][5]. In humans, hundreds of such pseudogenes exist, produced by the integration of 7SL RNA-derived sequences back into the genome, leading to truncated and typically nonfunctional copies[1][6][7]. RN7SL673P is one such variant; it does not produce a functional RNA and lacks biochemical or therapeutic relevance. While parental 7SL RNA is implicated in cancer signaling and viral assembly, these roles do not extend to its pseudogenes, including RN7SL673P[1][5][7]. There are no known interacting drugs, disease associations, or recognized biological functions attributable to RN7SL673P, and it is NOT considered a therapeutic target or a functional gene[7]. If this entry is being considered for drug target databases or functional annotations, it should be flagged as incorrect or out-of-scope.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 673, pseudogene (RN7SL673P).